BGN and Alzheimer disease: Among these highly significant proteins, we confirmed several targets outside of M42 matrisome members that were consistently validated across different proteomic platforms (Fig. 3C), including ESM1, PLA2G7, BGN, CSF1, and GCG, further reinforcing their changes in AD plasma.